Skip to content

Clinical trials

Phase 3 Chest Pain trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chest Pain Phase: Phase 3 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20071
20081
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Point Biomedical3
Amarin Pharma Inc.1
Gilead Sciences1
Harvard Vanguard Medical Associates1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chest Pain8
Coronary Artery Disease4
Acute Coronary Syndrome2
Angina Pectoris2
Heart Diseases2
Myocardial Infarction2
Myocardial Ischemia2
Arterial Occlusive Diseases1
Arteriosclerosis1
Cardiovascular Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.